Boston Scientific (BSX) — Research Summary as of August 6, 2026

Key Recent Catalysts (Last ~1–3 Months)

Q2 2026 Earnings Beat (July 29, 2026)

The most significant recent catalyst was Boston Scientific's Q2 2026 earnings report, released on July 29, 2026. The company generated net sales of $5.442 billion, representing 7.5% reported growth and 7.0% organic growth year-over-year [1]. The results exceeded Wall Street expectations, with the company delivering an earnings surprise of +3.61% and a revenue surprise of +1.07% for the quarter ended June 2026 [4]. The adjusted EPS came in at $0.835 against market expectations of $0.86 [7], though it should be noted that the positive earnings surprise percentage reported in [4] may reflect a different consensus figure or adjusted metric, so there is some ambiguity in the exact beat magnitude.